Filter
1234
Text search:
human
pharmaceutical
products
Featured
Recommendations
118
New Publications
332
Language
Document type
No document type
594
Studies & Reports
263
Guidelines
193
Manuals
72
Strategic & Response Plan
69
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
2
Infographics
1
Countries / Regions
Kenya
60
Global
51
Ethiopia
40
India
37
Nigeria
27
South Africa
27
Sierra Leone
26
Western and Central Europe
26
Uganda
24
Liberia
23
Rwanda
22
Ghana
21
Namibia
20
Zambia
18
Tanzania
18
Ukraine
17
Philippines
15
Africa
15
Nepal
14
Bangladesh
12
Malawi
12
Latin America and the Carribbean
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
504
Clinical Guidelines
89
Key Resources
64
Public Health
59
Women & Child Health
33
Pharmacy & Technologies
24
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
159
Pharmacy
130
COVID-19
72
TB
57
HIV
51
Mental Health
46
Planetary Health
38
NTDs
34
Rapid Response
28
Global Health Education
26
Conflict
22
NCDs
22
Caregiver
20
Health Financing Toolbox
19
Ebola & Marburg
17
2.0 Rapid Response
15
Malaria
13
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
The “United Nations Framework for the immediate socio-economic response to COVID-19: Shared responsibility, global solidarity and urgent action for people in need” calls for protecting jobs, businesses and livelihoods to set in motion a safe recovery of societies and economies as soon as possibl
...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us
...
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T
...
The active participation and engagement of health and care workers (HCWs) in health emergency preparedness, readiness and response is crucial to support risk communication, community engagement and infodemic management (RCCE-IM) interventions during emergencies. HCWs hold unique position
...
First report of a demonstration project
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel
...
3rd edition
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
Responding to community spread of COVID-19
recommended
Interim Guidance 7 March 2020
This document provides technical guidance for government authorities, health workers, and other key stakeholders to guide response to community spread. It will be updated as new information or technical guidance become available. For countries that are already preparin
...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub
...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was
...
